{
    "code": "02012552",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02012552",
    "time": "2020-02-25 10:11:15",
    "許可證字號": "衛署藥輸字第012552號",
    "註銷狀態": "已註銷",
    "註銷日期": "98\/03\/24",
    "註銷理由": "自請註銷",
    "有效日期": "93\/03\/10",
    "發證日期": "73\/03\/28",
    "許可證種類": "原料藥",
    "舊證字號": "13008206",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201255209",
    "中文品名": "次黃嘌呤核\/",
    "英文品名": "INOSINE",
    "適應症": "血管擴張劑",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "01製劑原料",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "0506901100  正豐貿易股份有限公司",
        "申請商地址": "台北巿松江路１２９號９樓",
        "主製造廠": ""
    },
    "CCC號列": "29335990900 其他之結構中含嘧啶環（不論是否氫化）或六氫???環之化合物Other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200005000",
            "成分名稱": "INOSINE",
            "含量描述": "90",
            "含量": "90.0000000000",
            "單位": "%"
        }
    ]
}